The increasing rates of opioid abuse and dependence, as well as
the alarming rise in the number of prescription opioid-related
overdoses and deaths in the US, has caused government
agencies around the globe to launch various initiatives in an
attempt to stem the tide of this devastating public health
crisis. Henry Riordan at Worldwide Clinical Trials reviews the
FDA’s Action Plan to Proactively Reduce Prescription Opioid
Abuse.